rgbp. like in one of my other P-Stocks, once people start "Feeling" the long term Value, nothing the Shorters can do as they will be overwhelmed by the positive sentiment most of the time? Can we reach that coveted position in the public's minds, I don't know, but RGBP has made a couple of important breakthroughs lately that places us in a pretty good position, and the next year or so will tell us how far we can go?
Then, the BioPharmas and Pharmaceutical Co's of the world is a tough place to be, as the rush to Clinical Trial passage is phenomenal at this time! Those who developed the most inclusive (mRNA) system, the broader number of product patents, and the safer the basic systems are, will be the Co's that survive the havoc in the Marketplace IMO?
Since we are one of the forerunners of the Stem Cell and mRNA delivery systems starting maybe 12+ years ago, our foundation is firmly set in the latest Science, where others will have to come to us to license-out our patents, for who would want to spend more time and money developing their own systems, knowing they would have to overcome our new Science Patents with newer and better systems of their own, in order for them to be Patented? Time is a vital component, and that seems to be on our side right now?
Ely Lilly Inc., a respected Pharmaceutical firm, has obtained rights to License-out one or more of our Patents when they see fit! That proves my assumption that to get ahead, Co's will have to contact us first or as soon as possible? Our new system, and since we have been early in the mRNA Science development, the chances are pretty good we have excellent Patent coverage, and that it is beginning to be respected in the Pharmacological field? IMO..
